GEN Exclusives

More »

GEN News Highlights

More »
Sep 17, 2007

Protein Involved in Breast Cancer’s Estrogen Response Uncovered

  • Transcription factor AP2C (TFAP2C) plays a central role in controlling multiple pathways of estrogen signaling in breast cancer, according to University of Iowa researchers.

    The investigators report that silencing expression of TFAP2C in hormone-responsive breast cancer cells decreased the amount of ER-alpha made by the cancer cell. This reduction, which resulted in expression down to 16% of the level normally made by breast cancer cells, also affected production of other downstream genes involved in cancer growth.
    In addition, silencing TFAP2C knocked out expression of another estrogen receptor called GPR30 that is found at the cancer cell membrane.

    The Iowa team also say that these effects inhibited tumor growth. Specifically, the treated cancer cells did not grow in response to estrogen, and establishment of tumors in mice was delayed.

    The findings were published in the September 15 issue of Cancer Research.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?